Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Barrett Esophagus × Prednisolone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lymphoma 17 Precursor Cell Lymphoblastic Leukemia-Lymphoma 16 Lymphoma, Large B-Cell, Diffuse 14 Hodgkin Disease 7 Lymphoma, Non-Hodgkin 5 Leukemia 5 Hemangioma 5 Lymphoma, Follicular 4 Prostatic Neoplasms 3 Immunoblastic Lymphadenopathy 3 Neurotoxicity Syndromes 2 Neoplasm, Residual 2 Lymphoma, T-Cell 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, B-Cell 2 Esophageal Stenosis 2 Enteropathy-Associated T-Cell Lymphoma 2 Vomiting 1 Thymoma 1 Recurrence 1 Pulmonary Disease, Chronic Obstructive 1 Philadelphia Chromosome 1 Neoplasms 1 Neoplasm Metastasis 1 Nausea 1 Myasthenia Gravis 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Mantle-Cell 1 Lymphoma, B-Cell, Marginal Zone 1

Interventions

Endoscopy 12 Endoscopy, Digestive System 8 Endoscopic Mucosal Resection 8 Gastroscopy 5 Biopsy 5 Specimen Handling 4 Omeprazole 4 Radiofrequency Ablation 3 Esomeprazole 3 Breath Tests 3 Proton Pump Inhibitors 2 Photochemotherapy 2 Narrow Band Imaging 2 Microscopy, Confocal 2 Endoscopes 2 Diagnostic Imaging 2 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 2 omeprazole, sodium bicarbonate drug combination 1 gluconic acid 1 chlorhexidine gluconate 1 candesartan cilexetil 1 candesartan 1 YF 476 1 Tomography, Optical Coherence 1 Tamoxifen 1 Surveys and Questionnaires 1 Standard of Care 1 Spectrum Analysis 1 Sampling Studies 1 Risk Assessment 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02004782 2025-03-27

BERST

Western Sydney Local Health District

Phase 4 Withdrawn

Gastrointestinal

Barrett Esophagus, Esophageal Stenosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡